term,pvalue,odds_ratio,log_pval
4-1BB-dependent immune response,0.0006442373709490262,20.52268244575937,3.190954086212693
AKT phosphorylation of nuclear targets,0.07896728809662318,13.527615334632877,1.1025527763201677
AKT signaling pathway,0.17242555973433366,5.53056884635832,0.7633983555136599
ALK1 pathway,0.1992380848391284,4.678812415654521,0.7006276415421238
AMPK signaling,0.019065855639752303,5.584185045723507,1.7197436996331927
AP-1 transcription factor network,0.0002925694698993818,9.418435855561604,3.533770995182712
ATF2 transcription factor network,0.0014826538072086762,8.831632653061224,2.8289602428829803
ATM pathway,0.06105411382445477,5.201752190237798,1.2142850679833417
ATM-dependent DNA damage response,0.030791295585270717,4.603846153846154,1.511572037186562
ATM-mediated phosphorylation of repair proteins,0.04815313595372715,24.354385964912282,1.3173754243639377
Actin cytoskeleton regulation,2.3237815041584317e-16,13.922137208255641,15.63380470932788
Actions of nitric oxide in the heart,0.3264587028502455,2.5856662933930568,0.48617174933104784
Activated AMPK stimulation of fatty-acid oxidation in muscle,0.144720643239773,6.760883690708251,0.8394695158354792
Activated NOTCH1 signaling in the nucleus,0.02816720085131926,8.156078431372547,1.5502563093943345
Activation of BH3-only proteins,0.1376515394741431,7.158926728586171,0.8612189271592329
Activation of C3 and C5,0.05595144311843891,20.294346978557503,1.2521887075218303
Activation of DNA fragmentation factor,0.00018391067799036778,33.59386767079074,3.7353930545701513
Activation of NMDA receptor upon glutamate binding and postsynaptic events,0.0036903261425102075,10.545900253592562,2.4329352502004733
Activation of NOXA and translocation to mitochondria,0.04815313595372715,24.354385964912282,1.3173754243639377
Activation of Rac,0.11609381364345954,8.69423558897243,0.9351909221399033
Activation of chaperones by IRE1 alpha,0.33198796512161605,2.53167641325536,0.478877659597191
Activation of the AP-1 family of transcription factors,0.0865145785419486,12.174269005847954,1.0629107035543401
Acute myeloid leukemia,2.3266386226171858e-08,20.271219512195124,7.633271066816849
Adaptive immune system,0.0001474608354832266,3.2658374935445003,3.8313233098013786
Adherens junction cell adhesion,0.0003777619826829794,8.87852865697177,3.4227817508656826
Adhesion and diapedesis of lymphocytes,0.11609381364345954,8.69423558897243,0.9351909221399033
Adipocytokine signaling pathway,0.10712045571172804,3.7008912655971478,0.9701275884169973
Adipogenesis,0.09775071526438894,2.8045982203351554,1.0098800560882006
Adrenergic pathway,0.3123842293969513,1.7899653979238754,0.5053108994386688
Advanced glycosylation endproduct receptor signaling,0.10878950577119445,9.363472784525417,0.9634129962322838
Agrin in postsynaptic differentiation,0.05887018693338069,5.3150895140664955,1.2301045851491557
Aldosterone-regulated sodium reabsorption,0.005239803654229963,9.225443786982249,2.2806849865815604
Alpha-4 beta-7 integrin signaling,6.21115095237041e-05,52.80050718512257,4.206827915773793
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling,0.006722477517616494,8.385153308230231,2.1724706415392347
Alpha-6 beta-4 integrin signaling pathway,5.8540647025107495e-06,23.066090042137944,5.232542481801767
Alpha-9 beta-1 integrin pathway,0.019054732263666243,10.198039215686274,1.719997149081751
Alpha-M beta-2 integrin signaling,0.004903398570787681,9.462448793809742,2.309502803866103
Alpha-V beta-3 integrin/OPN pathway,5.8540647025107495e-06,23.066090042137944,5.232542481801767
Alpha-synuclein signaling,0.00014771595873870022,17.076354679802957,3.8305725824283865
Alternative complement pathway,0.004170759522527345,24.491764705882357,2.3797848499648087
Alzheimer's disease,0.00280925501319827,4.554216867469879,2.551408835452069
Amoebiasis,0.0565300663959557,3.5718389153788705,1.247720504450013
Amyloids,0.06776799560788889,4.888941176470588,1.1689753594139327
Amyotrophic lateral sclerosis (ALS),5.158690612654146e-06,15.647590361445783,5.287460517725878
Androgen receptor regulation of biosynthesis and transcription,0.07237320241347016,4.700452488687783,1.1404222100224453
"Androgen receptor signaling, proteolysis, and transcription regulation",0.006182010939642185,5.810364145658264,2.208870230747636
Angiogenesis,1.3028859893477038e-06,32.79073432083202,5.885093586101313
Angiopoietin receptor Tie2-mediated signaling,8.084196720362235e-12,32.08024691358025,11.092363126932055
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling,0.04245882991237579,6.436532507739938,1.3720319783659807
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin,0.00019308668091717798,10.36327345309381,3.7142476827388475
"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",0.6224395253584343,0.9529411764705882,0.20590283713013435
Antigen-activated B-cell receptor generation of second messengers,1.4599040357351968e-06,7.0114335156515555,5.835675690873377
Antiviral mechanism by interferon-stimulated genes,0.4428371900719764,1.7341687552213867,0.35375591361803965
Apoptosis,0.0009065213919954684,4.274623767514271,3.04262194301252
Apoptosis intrinsic pathway,0.22518680029851765,4.054191033138402,0.6474570699731115
Apoptosis modulation and signaling,0.14249175842203288,3.0899478778853315,0.8462102540789237
Apoptosis regulation,0.13689614136660305,3.1705118411000766,0.8636087929676101
Apoptotic cleavage of cellular proteins,0.0093621332088001,15.30294117647059,2.0286251838200644
Apoptotic execution  phase,7.260706711861522e-05,12.961576846307388,4.139021105729055
Apoptotic signaling in response to DNA damage,0.1586864731320332,6.084210526315791,0.7994600921140469
Arf6 integrin-mediated signaling pathway,0.0632654492533992,5.0931372549019605,1.1988334036508002
Arf6 signal transduction regulation,0.03502641096032087,7.1951557093425595,1.4556043611117297
Arf6 vesicle-mediated transport,0.12333860106558601,8.114230019493178,0.9089009817483877
Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.024548062217232592,5.0470130501742725,1.6099827846643584
Asthma,0.22518680029851765,4.054191033138402,0.6474570699731115
Atypical NF-kappaB pathway,0.1376515394741431,7.158926728586171,0.8612189271592329
Axon guidance,3.185436961076682e-14,9.901929824561403,13.496830985065518
B cell survival pathway,0.13052435023717956,7.60672514619883,0.884308460071737
B lymphocyte cell surface molecules,0.09400038027098692,11.066985645933014,1.0268703894933098
BAD phosphorylation mediated by IGF1R signaling,0.0009628795963876405,17.588334742180898,3.016428015984149
BAD phosphorylation regulation,7.630891745524965e-05,20.63888888888889,4.117424707453887
BARD1 signaling events,0.21877907501970922,4.194192377495463,0.6599942181615012
BDNF signaling pathway,6.273047319585818e-05,5.040172447579854,4.20252143642927
"BRCA1, BRCA2 and ATR roles in cancer susceptibility",0.17242555973433366,5.53056884635832,0.7633983555136599
BTG family proteins and cell cycle regulation,0.004170759522527345,24.491764705882357,2.3797848499648087
Bacterial invasion of epithelial cells,2.7631928539175664e-05,11.370208105147865,4.558588802933891
Basal cell carcinoma,0.3694494827410325,2.2087187666135035,0.43244493715196763
Beta-1 integrin cell surface interactions,0.00022280685202488343,10.02800849913077,3.652071457345532
Beta-3 integrin cell surface interactions,6.494893190957309e-08,23.838984438984436,7.187427986540033
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling,0.0093621332088001,15.30294117647059,2.0286251838200644
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs),0.07135800684164549,15.219298245614034,1.146557289093872
Bioactive peptide-induced signaling pathway,2.3145552568476618e-05,16.823919728111346,4.63553244656941
Biological oxidations,0.10781920654756101,2.680991664147195,0.9673038685126121
Bladder cancer,0.005239803654229963,9.225443786982249,2.2806849865815604
Bone mineralization regulation,0.09400038027098692,11.066985645933014,1.0268703894933098
Bone remodeling,0.144720643239773,6.760883690708251,0.8394695158354792
C-Myb transcription factor network,0.0054790999792071375,6.023809523809524,2.2612907747575135
CARM1 and regulation of the estrogen receptor,0.1992380848391284,4.678812415654521,0.7006276415421238
CBL signaling regulation,1.530116045935906e-05,33.03650793650793,4.815275630490614
CBL-mediated ligand-induced downregulation of EGF receptors,0.005689103652387648,20.4078431372549,2.244956153549875
CCR3 signaling in eosinophils,0.015072657413321599,11.656582633053219,1.821810171826188
CD28 co-stimulation,0.02816720085131926,8.156078431372547,1.5502563093943345
CD28-dependent PI3K/Akt signaling,0.013835695733344222,12.24,1.858998997306896
CD28-dependent Vav1 pathway,0.09400038027098692,11.066985645933014,1.0268703894933098
CD8/T cell receptor downstream pathway,0.019065855639752303,5.584185045723507,1.7197436996331927
CDC42 signaling events,0.0002925694698993818,9.418435855561604,3.533770995182712
CDO in myogenesis,0.024966873813002343,8.739495798319327,1.6026358337303164
CREB phosphorylation,0.0018079446910869567,40.82745098039215,2.742814859658857
CREB transcription factor and its extracellular signals,0.0009628795963876405,17.588334742180898,3.016428015984149
CRMPs in Sema3A signaling,0.008366614320089122,16.32392156862745,2.077450250437934
CTCF pathway,0.02192733606655957,9.41266968325792,1.6590141271855783
CTL mediated immune response against target cells,0.10878950577119445,9.363472784525417,0.9634129962322838
CTLA4 inhibitory signaling,0.015072657413321599,11.656582633053219,1.821810171826188
CXCR4 signaling pathway,2.2542889062669034e-10,14.802142857142856,9.646990426197139
Cadmium-induced DNA biosynthesis and proliferation in macrophages,0.1376515394741431,7.158926728586171,0.8612189271592329
Calcineurin in effects in keratinocyte differentiation,0.15173213217560824,6.404739919975377,0.8189224393262989
Calcineurin-dependent NFAT signaling role in lymphocytes,9.475213544239835e-05,12.197369965950452,4.023410993492878
Calcitonin-like ligand receptors,8.488911249391927e-05,46.19822485207101,4.071148006894098
Calcium regulation in the cardiac cell,0.710049747928261,0.8116095608147887,0.1487112224163441
Calcium signaling by HBx of hepatitis B virus,0.12333860106558601,8.114230019493178,0.9089009817483877
Calcium signaling pathway,0.1815643407568895,2.082974717590102,0.7409694428920142
Carbohydrate metabolism,0.857995846846477,0.512454896105512,0.06651481436111151
Caspase cascade in apoptosis,0.38991043785633434,2.0585786500148675,0.4090351386444507
Cell adhesion molecules (CAMs),0.024543523835402908,3.7908424908424907,1.6100630833203806
Cell cycle,0.5119327541995129,1.0782010582010582,0.29078708277046006
Cell cycle checkpoints,0.6221207793623904,1.0351876843104912,0.20612529261053525
Cell cycle progression regulation by PLK3,0.15173213217560824,6.404739919975377,0.8189224393262989
Cell cycle: G1/S checkpoint,0.21231866831281923,4.344193817878028,0.6730118184161881
Cell cycle: G2/M checkpoint,0.02192733606655957,9.41266968325792,1.6590141271855783
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model,0.0004568811365712165,12.373809523809525,3.3401967724589525
Cell differentiation pathway,0.012645313047109327,12.884829721362227,1.8980704148012453
Cell surface interactions at the vascular wall,8.640257652662572e-08,13.317020973034671,7.063473306657542
Cell to cell adhesion signaling,0.0093621332088001,15.30294117647059,2.0286251838200644
Cell-cell communication,9.925221737909055e-05,7.141414141414141,4.003259781947757
Cells and molecules involved in local acute inflammatory response,0.0093621332088001,15.30294117647059,2.0286251838200644
Ceramide signaling pathway,0.007982063529788636,7.848797683494901,2.0978848199588054
Chagas disease,0.010947277490851818,4.886138613861386,1.960693873308917
Chemokine signaling pathway,0.00017649447026503687,5.533637094612704,3.7532688969107286
Chromatin remodeling by nuclear receptors to facilitate initiation of transcription in carcinoma cells,0.07135800684164549,15.219298245614034,1.146557289093872
Chromosome maintenance,0.5757490939345986,1.1766876738772498,0.2397667368192479
Chronic myeloid leukemia,0.0003549043704560568,9.007636900112818,3.449888652516983
Chylomicron-mediated lipid transport,0.0093621332088001,15.30294117647059,2.0286251838200644
Ck1/Cdk5 regulation by type 1 glutamate receptors,0.19261703641072386,4.866198830409357,0.7153053034422358
Class B GPCRs (secretin family receptors),0.04437607554469008,3.957816377171216,1.3528511077968315
Collagen binding in corneal epithelia mediated by Erk and PI-3 Kinase,0.0009628795963876405,17.588334742180898,3.016428015984149
Colorectal cancer,0.014972053430044674,6.144378698224852,1.8247186317090873
"Complement activation, classical pathway",0.1376515394741431,7.158926728586171,0.8612189271592329
Complement and coagulation cascades,0.11505646770753764,3.539471440750213,0.9390889631687915
Complement cascade,0.13411727161466136,3.2123839009287924,0.8725152901280192
Complement cascade regulation,0.006529195559483611,18.83710407239819,2.185140323410745
Control of cell cycle and breast tumor growth by estrogen-responsive protein Efp,0.00033741224760654924,26.391377852916314,3.4718391571606393
Control of gene expression by vitamin D receptor,0.20580514960848267,4.50530647606671,0.6865437626223331
Cooperation of prefoldin and TriC/CCT  in actin and tubulin folding,0.001521512945632253,14.771360946745562,2.8177243481413488
Corticosteroids and cardioprotection,0.144720643239773,6.760883690708251,0.8394695158354792
Corticotropin releasing hormone pathway,0.019054732263666243,10.198039215686274,1.719997149081751
Costimulation by the CD28 family,2.2623359892017848e-06,13.345638200183656,5.645442895688059
Cyclin A-Cdk2-associated events at S phase entry,0.45195759599796037,1.6858349577647822,0.34490231007353606
Cyclin A/B1-associated events during G2/M transition,0.12333860106558601,8.114230019493178,0.9089009817483877
Cytokine-cytokine receptor interaction,7.116679425326937e-05,4.96045524691358,4.147722596762256
Cytokines and inflammatory response,0.256450033837241,3.474185463659148,0.5909972392953379
Cytoplasmic ribosomal proteins,0.2245950986449649,2.2782847718526664,0.6485997256109459
Cytosolic sulfonation of small molecules,0.00018391067799036778,33.59386767079074,3.7353930545701513
DARPP-32 events,0.19261703641072386,4.866198830409357,0.7153053034422358
DCC role in regulating apoptosis,0.0865145785419486,12.174269005847954,1.0629107035543401
DCC-mediated attractive signaling,5.528364896393187e-06,45.05844155844156,5.257403299342257
DNA repair,0.5827047376985224,1.1541631857421333,0.23455145085105356
Deposition of new CENP-A-containing nucleosomes at the centromere,0.31526331069217756,2.7008447043534765,0.5013265680756518
Deregulation of CDK5 in Alzheimer's disease,0.0865145785419486,12.174269005847954,1.0629107035543401
Developmental biology,7.246617418596163e-08,5.544682210156499,7.139864666428164
Diabetes pathways,0.3123842293969513,1.7899653979238754,0.5053108994386688
Differentiation pathway in PC12 cells,0.005257239973293419,6.098471487360376,2.279242198614351
Dilated cardiomyopathy,0.009587578554318422,5.0886107020127636,2.018291064704787
Disease,7.252059473245814e-07,4.0524306950582565,6.1395386429664125
Dorso-ventral axis formation,0.18594156317429864,5.069200779727096,0.7306235223330885
Double stranded RNA-induced gene expression,0.10878950577119445,9.363472784525417,0.9634129962322838
Double-strand break repair,0.17242555973433366,5.53056884635832,0.7633983555136599
Down syndrome cell adhesion molecule (DSCAM) interactions,0.09400038027098692,11.066985645933014,1.0268703894933098
Downregulation of ERBB2-ERBB3 signaling,0.10878950577119445,9.363472784525417,0.9634129962322838
Downregulation of MTA-3 in ER-negative breast tumors,0.144720643239773,6.760883690708251,0.8394695158354792
Downstream signaling events Of B cell receptor (BCR),0.557851586088565,1.237021124239169,0.25348132779367755
E-cadherin keratinocyte pathway,0.013835695733344222,12.24,1.858998997306896
E-cadherin nascent AJ-like junctions pathway,0.04245882991237579,6.436532507739938,1.3720319783659807
E2F transcription factor network,0.12586120398012443,3.344883158742949,0.9001081181357807
ECM-receptor interaction,7.08533104808989e-05,9.493213359768188,4.14963985339113
EGF receptor (ErbB1) signaling pathway,1.4949538649922335e-08,30.426959247648902,7.825372209672967
EGF receptor transactivation by GPCRs in cardiac hypertrophy,0.033256108117996744,7.413547237076648,1.4781285765769845
EGF/EGFR signaling pathway,2.6443407003332355e-06,8.591494072604824,5.577682590509264
EGFR interaction with phospholipase C-gamma,0.2746026070256716,3.1994459833795013,0.5612953439692971
EGFR1 pathway,3.8838504242891084e-05,6.95811606391926,4.410737504087598
EPO receptor signaling,0.0029149306946482426,11.536242603550297,2.535371766561793
ERBB signaling pathway,1.1410475611268356e-06,11.629380431735353,5.942696252948613
ERBB1 downstream pathway,0.0018863632940675202,6.083714923094986,2.724374662916408
ERBB1 internalization pathway,0.04637620879892532,6.1141176470588245,1.333704757315201
ERBB2 role in signal transduction and oncology,7.099507104537675e-08,35.81239242685026,7.148771801873893
ERBB2/ERBB3 signaling events,3.258962290794081e-05,15.55988023952096,4.486920664694352
ERBB4 signaling events,0.0002857746591524548,14.144897959183673,3.5439762845660017
ERK activation,0.04815313595372715,24.354385964912282,1.3173754243639377
ERK inactivation,0.004902647513188036,22.26417112299465,2.3095693302048463
ERK1/ERK2 MAPK pathway,1.134614339427315e-06,14.934052388289677,5.945151732057405
ERK5 role in neuronal survival pathway,2.933761006395501e-06,27.082790939859407,5.532575268076652
Effect of METS on macrophage differentiation,0.144720643239773,6.760883690708251,0.8394695158354792
Endochondral ossification,0.017639376996744782,5.759245562130178,1.7535167577333348
Endocytosis,0.00026759746233887303,5.188332914256977,3.572518009355074
Endometrial cancer,0.009371591264287884,7.37680473372781,2.0281866611266435
Endothelins,0.016274848902787856,5.945600305401794,1.7884830347714495
Energy-dependent regulation of mTOR by LKB1-AMPK,0.1376515394741431,7.158926728586171,0.8612189271592329
Ephrin receptor A forward pathway,3.6873601983564334e-07,25.923140839218945,6.433284436432984
Ephrin receptor B forward pathway,2.202175923657851e-15,35.39570230607966,14.657147989804777
Epidermal growth factor receptor (EGFR) pathway,2.8799876417863422e-08,12.542967804405713,7.5406093758225445
Epithelial cell signaling in Helicobacter pylori infection,0.10974895123626457,3.6454784899034243,0.9595996211949924
Estrogen receptor signaling pathway,0.1586864731320332,6.084210526315791,0.7994600921140469
Estrogen receptor transcription factor targets,0.1992380848391284,4.678812415654521,0.7006276415421238
FGF signaling pathway,2.7668174072000332e-15,34.67167244256193,14.558019500657394
FGFR ligand binding and activation,6.732515975720465e-10,51.934759358288765,9.171822607369254
FGFR1b ligand binding and activation,1.0605270462967387e-05,123.22485207100591,4.97447825132691
FGFR2b ligand binding and activation,1.844731264567695e-05,92.41420118343196,4.734066891735788
FGFR3 ligand binding and activation,2.933159853117878e-06,55.076719576719576,5.532664267931402
FGFR3b ligand binding and activation,0.0018079446910869567,40.82745098039215,2.742814859658857
FGFR4 ligand binding and activation,4.08019220518496e-06,49.56666666666666,5.389319378163773
FOSB gene expression and drug abuse,0.04815313595372715,24.354385964912282,1.3173754243639377
FOXM1 transcription factor network,0.292314528303283,2.9649122807017547,0.5341495992674383
FRA pathway,0.2686012433127524,3.286075549233444,0.5708919813820542
FRS2-mediated activation,0.01150235345890359,13.601307189542483,1.9392132909816573
FRS2-mediated cascade,2.955109359371411e-11,37.041955274094605,10.529426442602444
FSH regulation of apoptosis,6.683543814629117e-05,5.0,4.174993200542627
FSH signaling pathway,0.001521512945632253,14.771360946745562,2.8177243481413488
FXR and LXR regulation of cholesterol metabolism,0.06368622860806064,17.394319131161236,1.1959544685457109
Factors involved in megakaryocyte development and platelet production,0.27608318864454684,1.964326375711575,0.5589600377692556
Fas signaling pathway,5.155610008138213e-06,9.35862691960253,5.287719941923634
"Fatty acid, triacylglycerol, and ketone body metabolism",0.4180115860727887,1.412859097127223,0.37881168067055
Fc epsilon receptor I signaling in mast cells,2.3145552568476618e-05,16.823919728111346,4.63553244656941
Fc epsilon receptor I signaling pathway,3.0197883854169983e-07,14.062330623306233,6.520023489581164
Fc gamma receptor-mediated phagocytosis,0.00013162477793550196,8.422498984702857,3.8806623485051652
Fibroblast growth factor 1,0.1992380848391284,4.678812415654521,0.7006276415421238
Fibroblast growth factor receptor pathway,3.9349765786437753e-16,23.633048433048433,15.405057848259437
Fluoropyrimidine activity,0.2440981413739806,3.6850965798334223,0.612435527400088
Focal adhesion,8.600433317116226e-13,11.153679653679653,12.065479667071354
Folate metabolism,0.015615750791823271,6.043360170724609,1.8064371304278701
FoxO family signaling,0.007982063529788636,7.848797683494901,2.0978848199588054
G alpha (12/13) signaling events,0.13411727161466136,3.2123839009287924,0.8725152901280192
G alpha (i) signaling events,0.8084710211027359,0.6062182256310793,0.09233554236330213
G alpha (s) signaling events,0.08496597202900709,2.9881656804733727,1.0707549698020111
G alpha (z) signaling events,0.31526331069217756,2.7008447043534765,0.5013265680756518
G alpha 12 pathway,5.468003864267397e-05,13.827677977378576,4.262171187185888
G alpha 13 pathway,0.0023538811822348313,7.724702380952381,2.6282154629888064
G alpha i pathway,0.0002791162168989012,7.272780442156978,3.55421492988506
G alpha q pathway,0.4428371900719764,1.7341687552213867,0.35375591361803965
G alpha s pathway,0.017605319178838355,4.214692714692715,1.7543560969015684
G-protein signaling pathways,0.5467548368015585,1.2762696214219758,0.26220736633891145
G-protein-independent seven transmembrane receptor signaling,0.15173213217560824,6.404739919975377,0.8189224393262989
G-protein-mediated events,0.309596433409738,2.762360446570973,0.5092040510879564
G1 to S cell cycle control,0.42887290202517714,1.8120799511215853,0.3676713934268627
G13 signaling pathway,0.28055501156703794,3.1172589593642224,0.5519819690689869
GAB1 signalosome,0.004270676101530573,9.974892051815129,2.3695033652746766
GATA3-mediated activation of Th2 cytokine expression,0.0006442373709490262,20.52268244575937,3.190954086212693
GM-CSF-mediated signaling events,5.210124316334795e-07,24.248348231636225,6.2831519140797285
GPCR ligand binding,0.4353655612189362,1.1946296946296946,0.3611459279915707
GRB2-SOS provides linkage to MAPK signaling for integrins,1.2157433632847433e-05,35.397959183673464,4.915158092556973
GRB7 events in ERBB2 signaling,0.04815313595372715,24.354385964912282,1.3173754243639377
Gap junction pathway,5.926936168183547e-08,13.969325153374234,7.227169749993129
Gastrin pathway,0.309596433409738,2.762360446570973,0.5092040510879564
Gastrin-CREB signaling pathway via PKC and MAPK,0.02801616494075912,3.057153020691291,1.5525913144127328
Gene expression,0.6854873720269097,0.8760914760914761,0.1640005413260304
Gene expression regulation in early pancreatic precursor cells,0.07135800684164549,15.219298245614034,1.146557289093872
Generation of second messenger molecules,0.000232410734767711,15.003607503607505,3.6337438162872466
Generic transcription pathway,0.37452663277827875,1.302139037433155,0.4265172939661549
Glioma,1.134614339427315e-06,14.934052388289677,5.945151732057405
Glycoprotein 1b-IX-V activation signaling,0.0865145785419486,12.174269005847954,1.0629107035543401
Glycoprotein VI-mediated activation cascade,0.002681075275549808,11.90895209009353,2.5716909923218716
Glycosaminoglycan metabolism,0.599601793480633,1.1014354066985645,0.22213707679511
GnRH signaling pathway,0.0015270875495096922,6.398851780974134,2.8161360636776953
Granule cell survival pathway,0.049064103601948114,3.7938754346367354,1.3092361312794156
Growth hormone receptor signaling,2.916067475056971e-05,15.959619223092275,4.535202431072213
HES/HEY pathway,0.06105411382445477,5.201752190237798,1.2142850679833417
HIF-1 degradation in normoxia,0.5197739341743084,1.3782562466772994,0.28418550345775606
HIF-1 transcriptional activity in hypoxia,0.4241412484029208,1.8396243133085237,0.3724894896655733
HIV factor interactions with host,0.28517943459655465,1.9176470588235293,0.5448817963631849
HIV infection,0.49171155600341426,1.2195684303872303,0.3082895849790242
HIV-1 Nef as negative effector of Fas and TNF,0.0013926067372053994,8.992640692640693,2.856171508109131
HIV-induced T cell apoptosis,0.07896728809662318,13.527615334632877,1.1025527763201677
HNF3A pathway,0.309596433409738,2.762360446570973,0.5092040510879564
Heart development,3.258962290794081e-05,15.55988023952096,4.486920664694352
Hematopoietic cell lineage,3.0417763381420457e-09,16.21268948273168,8.516872722788545
Hemostasis pathway,1.8679040803850275e-09,5.972043136795217,8.728645429192143
Human cytomegalovirus and MAP kinase pathways,1.530116045935906e-05,33.03650793650793,4.815275630490614
Huntington's disease,0.19392744680221272,2.013720007802848,0.7123607203118003
Hyaluronan metabolism,0.11609381364345954,8.69423558897243,0.9351909221399033
Hypertrophy pathway,0.0006442373709490262,20.52268244575937,3.190954086212693
Hypothetical network for drug addiction,0.029825782358277736,7.8925996204933595,1.5254081555561432
Hypoxia and p53 in the cardiovascular system,0.17921122039723542,5.2898550724637685,0.7466348026869893
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,0.15173213217560824,6.404739919975377,0.8189224393262989
IGF-1 receptor and longevity,0.01150235345890359,13.601307189542483,1.9392132909816573
IGF1 pathway,4.197946856056462e-06,24.913772455089823,5.376963063673465
IGF1 receptor signaling through beta-arrestin,0.19261703641072386,4.866198830409357,0.7153053034422358
IGF1 signaling pathway,0.0007414861847603253,19.44160697601993,3.1298969362583247
Immune system,2.926355174521667e-11,4.694578224257645,10.533672964275732
"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",1.1564435840121158e-08,7.385422154111393,7.936875549015153
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell,0.07588693380155209,3.142315278409953,1.119832994412573
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages,0.22518680029851765,4.054191033138402,0.6474570699731115
Inflammatory response pathway,0.026547316655460486,8.437728194726166,1.5759793698977917
Influence of Ras and Rho proteins on G1 to S transition,0.024966873813002343,8.739495798319327,1.6026358337303164
Inhibition of T cell receptor signaling by activated Csk,0.01150235345890359,13.601307189542483,1.9392132909816573
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP,0.1992380848391284,4.678812415654521,0.7006276415421238
Inhibition of cellular proliferation by Gleevec,0.017682993747721306,10.641943734015346,1.7524442066278376
Inhibition of platelet activation by aspirin,0.13052435023717956,7.60672514619883,0.884308460071737
Inhibitor of DNA binding (ID) signaling pathway,0.008366614320089122,16.32392156862745,2.077450250437934
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding,0.11609381364345954,8.69423558897243,0.9351909221399033
Innate immune system,0.0013295883991887483,3.642573925394039,2.87628278281259
Insulin signaling pathway,7.486335019752341e-08,6.901994629842731,7.125730741745487
Integrated breast cancer pathway,0.3571823518317891,1.6109855862874953,0.4471100074862231
Integrated cancer pathway,0.256450033837241,3.474185463659148,0.5909972392953379
Integrin alpha-2b beta-3 signaling,0.06368622860806064,17.394319131161236,1.1959544685457109
Integrin beta-2 pathway,0.024966873813002343,8.739495798319327,1.6026358337303164
Integrin beta-5 pathway,1.2157433632847433e-05,35.397959183673464,4.915158092556973
Integrin cell surface interactions,5.302040642102778e-07,12.976860537836147,6.275556947562315
Integrin family cell surface interactions,0.0013666696568990042,15.38757396449704,2.864336447775549
Integrin signaling pathway,4.459635201997681e-05,6.816084377059987,4.350700665108265
Integrin-mediated cell adhesion,1.8198037603948095e-06,10.875950694990822,5.739975441890027
Integrins in angiogenesis,1.0622785590991705e-08,17.369213608477413,7.9737615841805995
Interferon alpha signaling regulation,0.019054732263666243,10.198039215686274,1.719997149081751
Interferon alpha/beta signaling,0.016274848902787856,5.945600305401794,1.7884830347714495
Interferon gamma signaling regulation,0.006529195559483611,18.83710407239819,2.185140323410745
Interferon signaling,7.844550296401284e-05,6.2617785184063015,4.1054319481113835
Interferon-beta enhancer pathway,0.22518680029851765,4.054191033138402,0.6474570699731115
Interferon-gamma signaling pathway,4.882155172359226e-10,16.288355822088956,9.311388421266969
Interleukin receptor SHC signaling,0.023426625887066368,9.063616557734205,1.6302902578883287
Interleukin-1 regulation of extracellular matrix,6.308938097238208e-05,7.7085592769803295,4.200043733833477
Interleukin-1 signaling pathway,0.000605614613511191,6.237349397590362,3.2178036538337773
Interleukin-1-beta (IL-1b) processing pathway,0.05595144311843891,20.294346978557503,1.2521887075218303
Interleukin-10 anti-inflammatory signaling pathway,0.00033741224760654924,26.391377852916314,3.4718391571606393
Interleukin-11 pathway,0.17921122039723542,5.2898550724637685,0.7466348026869893
Interleukin-12-mediated signaling events,0.002109670346958071,7.974654377880183,2.6757854014236018
Interleukin-12/STAT4 pathway,0.006330976300767159,8.580569698637678,2.1985293122035823
Interleukin-17 signaling pathway,0.12333860106558601,8.114230019493178,0.9089009817483877
Interleukin-2 receptor beta chain in T cell activation,0.009371591264287884,7.37680473372781,2.0281866611266435
Interleukin-2 signaling pathway,1.4387152512575878e-09,4.537687429123441,8.842025152584968
Interleukin-2/PI3K pathway,0.03502641096032087,7.1951557093425595,1.4556043611117297
Interleukin-2/STAT5 pathway,0.026547316655460486,8.437728194726166,1.5759793698977917
Interleukin-22 soluble receptor signaling pathway,0.10878950577119445,9.363472784525417,0.9634129962322838
Interleukin-23-mediated signaling events,0.0036903261425102075,10.545900253592562,2.4329352502004733
Interleukin-27-mediated signaling events,0.0013666696568990042,15.38757396449704,2.864336447775549
Interleukin-3 regulation of hematopoietic cells,0.1586864731320332,6.084210526315791,0.7994600921140469
Interleukin-3 signaling pathway,8.947791742491125e-08,22.614296814296814,7.048284132548078
"Interleukin-3, interleukin-5, and GM-CSF signaling",1.9750312277273277e-06,18.78433734939759,5.704426033241347
Interleukin-4 regulation of apoptosis,4.750500177505704e-08,7.177215189873418,7.323260661344695
Interleukin-4 signaling pathway,2.537483665468952e-05,8.974025974025974,4.595596744751452
Interleukin-5 regulation of apoptosis,3.1427570217327035e-06,8.400757849151931,5.502689194610748
Interleukin-5 signaling pathway,5.468003864267397e-05,13.827677977378576,4.262171187185888
Interleukin-6 regulation of target genes,0.11609381364345954,8.69423558897243,0.9351909221399033
Interleukin-6 signaling pathway,7.351556415535029e-09,18.19894829097283,8.133620705661295
Interleukin-7 interactions in immune response,0.2502993776462155,3.5765393876848988,0.6015402302365647
Interleukin-7 signaling pathway,0.00020861055242731773,15.473214285714286,3.6806637268536764
Interleukin-9 regulation of target genes,0.1992380848391284,4.678812415654521,0.7006276415421238
Interleukin-9 signaling pathway,0.00033741224760654924,26.391377852916314,3.4718391571606393
Intestinal immune network for IgA production,0.33198796512161605,2.53167641325536,0.478877659597191
Ion channel transport,1.1632143986378618e-05,13.407056798623064,4.934340230616513
Ion transport by P-type ATPases,5.210124316334795e-07,24.248348231636225,6.2831519140797285
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.13052435023717956,7.60672514619883,0.884308460071737
JNK/MAPK pathway,5.158690612654146e-06,15.647590361445783,5.287460517725878
Jak-STAT signaling pathway,0.0002501960092679709,5.242886178861788,3.6017196217677836
KIT signaling regulation,0.00033741224760654924,26.391377852916314,3.4718391571606393
Keratinocyte differentiation,7.868677446179506e-06,14.44114921223355,5.104098256979408
Kit receptor signaling pathway,1.5090514623278156e-08,21.568240788790867,7.821295949472985
Kit receptor transcriptional targets,0.04815313595372715,24.354385964912282,1.3173754243639377
Klotho-mediated ligand binding,0.05595144311843891,20.294346978557503,1.2521887075218303
L1CAM interactions,1.3193053966412206e-05,9.99862258953168,4.879654661069359
LKB1 signaling events,0.007128080725512299,8.198422090729784,2.1470273905584403
LPA receptor mediated events,0.002109670346958071,7.974654377880183,2.6757854014236018
Lck and Fyn tyrosine kinases in initiation of T cell receptor activation,0.00018391067799036778,33.59386767079074,3.7353930545701513
Lectin-induced complement pathway,0.11609381364345954,8.69423558897243,0.9351909221399033
Leishmaniasis,0.0003331083617289795,9.140542444522719,3.477414465455998
Leptin influence on immune response,0.0022154948459176043,5.853010959213648,2.654529255965092
Leptin signaling pathway,1.1632143986378618e-05,13.407056798623064,4.934340230616513
Leukocyte transendothelial migration,0.016202945191549443,4.326232247284879,1.7904060370510417
Lipid and lipoprotein metabolism,0.37378061931854656,1.2558182603864436,0.4273832207239537
"Lipid digestion, mobilization, and transport",0.06105411382445477,5.201752190237798,1.2142850679833417
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),0.23667117343478392,2.195760466348702,0.6258546359475351
Lipoprotein metabolism,0.024966873813002343,8.739495798319327,1.6026358337303164
Lissencephaly gene (LIS1) in neuronal migration and development,0.15173213217560824,6.404739919975377,0.8189224393262989
Long-term depression,0.4428371900719764,1.7341687552213867,0.35375591361803965
Long-term potentiation,0.0027556459638260703,7.377754086709311,2.5597765798824574
Low-density lipoprotein (LDL) pathway during atherogenesis,0.05595144311843891,20.294346978557503,1.2521887075218303
MAL role in Rho-mediated activation of SRF,0.15173213217560824,6.404739919975377,0.8189224393262989
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35,0.005689103652387648,20.4078431372549,2.244956153549875
MAP kinase inactivation of SMRT corepressor,0.11609381364345954,8.69423558897243,0.9351909221399033
MAP kinase pathway regulation through dual specificity phosphatases,0.0028744755468461548,30.61764705882353,2.541441381543994
MAP kinase signaling pathway,3.6617558074447835e-07,13.680949241924854,6.436310620988805
MAPK cascade role in angiogenesis,1.0212706738899353e-06,15.19226750261233,5.990859138816503
MAPK signaling pathway,2.1332671835905096e-23,15.228317272053372,22.670954747414072
MAPK/TRK pathway,1.2125914635458657e-08,31.515151515151516,7.916285493455477
MEF2D role in T cell apoptosis,1.0672827080230513e-05,20.08595711802202,4.971720526899972
Malaria,0.34830643803186684,2.382410274051141,0.45803849804858676
Mammalian calpain regulation of cell motility,0.20580514960848267,4.50530647606671,0.6865437626223331
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha,0.011983103056989157,6.704572350726196,1.9214307056508162
Meiosis,0.4995299440293676,1.4616360177552314,0.30143847312981437
Meiotic recombination,0.3642285378140338,2.249729261425168,0.4386260296294804
Meiotic synapsis,0.3694494827410325,2.2087187666135035,0.43244493715196763
Melanocyte development and pigmentation pathway,0.00018391067799036778,33.59386767079074,3.7353930545701513
Melanogenesis,0.20359353680115685,2.4385882352941177,0.691236013055055
Melanoma,7.077923151136703e-16,31.730685290266262,15.150094157044428
Metabolism,0.9928003093004,0.43144503479757534,0.0031380962077189748
Metapathway biotransformation,0.056034648798630786,2.8762183235867447,1.2515433456951728
MicroRNA regulation of DNA damage response,0.02055443854663566,5.4194222067525235,1.6870943816629158
MicroRNAs in cardiomyocyte hypertrophy,5.302040642102778e-07,12.976860537836147,6.275556947562315
MicroRNAs in muscle cell differentiation,0.026547316655460486,8.437728194726166,1.5759793698977917
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,0.19169730822525236,2.5406862745098033,0.7173839853542117
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family,0.016355364487588318,11.12620320855615,1.7863397729584753
Mitochondrial pathway of apoptosis: caspases,0.13411727161466136,3.2123839009287924,0.8725152901280192
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family,0.021322050231730637,5.340622588114227,1.6711710378482212
Mitotic G1-G1/S phases,0.6744102657237397,0.8963829326402427,0.17107582759855613
Mitotic G2-G2/M phases,0.16243412142651956,2.837482900136799,0.7893227362358127
Modulation of interferon signaling by chaperones,0.016355364487588318,11.12620320855615,1.7863397729584753
Monoamine transport,0.2502993776462155,3.5765393876848988,0.6015402302365647
Monocyte and its surface molecules,0.004170759522527345,24.491764705882357,2.3797848499648087
Mu-calpain pathway,0.12333860106558601,8.114230019493178,0.9089009817483877
Muscle contraction,0.3374720980985184,2.4798902016947126,0.4717621284411706
Myc active pathway,0.03369845270687466,4.4368004562629215,1.4723900396714884
Myc repressed pathway,0.12313739125530188,3.391503267973856,0.909610051454528
Myometrial relaxation and contraction pathways,0.13648576782752603,2.3987701589511543,0.864912632698111
N-cadherin signaling events,0.0029149306946482426,11.536242603550297,2.535371766561793
NCAM signaling for neurite out-growth,0.0002925694698993818,9.418435855561604,3.533770995182712
NCAM1 interactions,0.309596433409738,2.762360446570973,0.5092040510879564
NF-kappaB activation by non-typeable Hemophilus influenzae,0.02816720085131926,8.156078431372547,1.5502563093943345
NFAT involvement in hypertrophy of the heart,0.0026168810909287903,7.48989898989899,2.5822160109202006
NGF signaling via TRKA from the plasma membrane,1.9641735832972334e-06,8.929256134969325,5.706820134198295
NICD trafficking to the nucleus,0.10878950577119445,9.363472784525417,0.9634129962322838
NO2-dependent IL-12 pathway in NK cells,0.1376515394741431,7.158926728586171,0.8612189271592329
NOD signaling pathway,0.15668384605466093,2.9053221288515405,0.804975776543269
Natural killer cell receptor signaling pathway,0.0001427843673031714,11.105645851154833,3.8453193385375237
Natural killer cell-mediated cytotoxicity,2.0957315180010082e-07,9.982638888888888,6.6786643551420815
Nectin adhesion pathway,1.718617040811401e-07,30.076626506024095,6.764820886309591
Nef in HIV-1 replication and disease pathogenesis,0.023426625887066368,9.063616557734205,1.6302902578883287
Nef-induced signal transduction,0.002312002739381665,34.99327731092436,2.6360116556764064
Negative regulation of FGFR signaling,3.7597968821287895e-11,35.88266871165644,10.424835616602497
Nephrin interactions,0.0008475980935819131,18.46863905325444,3.071810028775526
Nerve growth factor (NGF) pathway,0.012645313047109327,12.884829721362227,1.8980704148012453
Netrin mediated repulsion signals,1.3712349364636203e-06,70.81972789115646,5.862888130280796
Netrin-1 signaling,2.6018408185390206e-05,16.38039710053577,4.584719277238241
Netrin-mediated signaling events,7.810384710480605e-09,33.94265734265734,8.107327573866108
Neural crest differentiation,0.0069424494854856845,5.611471861471863,2.1584872715711705
Neuroactive ligand-receptor interaction,0.65726001993936,0.8924245713045366,0.18226278434491233
Neurofascin interactions,0.06368622860806064,17.394319131161236,1.1959544685457109
Neuronal system,0.4117957031986371,1.298005853987239,0.3853181892547949
Neuroregulin receptor degredation protein-1 controls ErbB3 receptor recycling,0.04815313595372715,24.354385964912282,1.3173754243639377
Neurotrophic factor-mediated Trk receptor signaling,1.6177911316312723e-09,22.060405851816896,8.791077549618313
Neurotrophin signaling pathway,4.002188295385233e-11,14.856118283129206,10.397702482485652
Nicotine activity on dopaminergic neurons,0.1655841291986373,5.7942077415761615,0.7809812915352176
Nicotinic acetylcholine receptor role in the regulation of apoptosis,0.01040767169280418,14.402076124567476,1.9826464159326678
Nitric oxide signaling pathway,0.17242555973433366,5.53056884635832,0.7633983555136599
Non-small cell lung cancer,0.01037143620089259,7.092398725534821,1.9841610998371613
Notch receptor processing,0.09400038027098692,11.066985645933014,1.0268703894933098
Notch signaling pathway,6.647333372017325e-05,7.641159420289855,4.177352540272498
Nuclear beta-catenin signaling and target gene transcription regulation,0.004430007013713273,6.416512059369203,2.3535955861889932
Nuclear events mediated by MAP kinases,0.0001150433055897115,18.343033509700174,3.9391386480082535
Nuclear receptor transcription pathway,0.06776799560788889,4.888941176470588,1.1689753594139327
Nuclear receptors,0.0405494222218335,6.610810810810811,1.3920153295578106
Nuclear signaling by ErbB4,0.04440131307377591,6.271191553544495,1.352604186365943
Nucleotide metabolism,0.4428371900719764,1.7341687552213867,0.35375591361803965
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.3264587028502455,2.5856662933930568,0.48617174933104784
Oncostatin M,1.0650702076383242e-05,5.132000000000001,4.972621763319197
Oocyte meiosis,0.014445572018231004,4.484415584415585,1.8402652562121253
Opioid signaling,0.14249175842203288,3.0899478778853315,0.8462102540789237
Osteoblast signaling,9.771730436233079e-08,62.32934131736527,7.010028522016984
Osteoclast signaling,1.2157433632847433e-05,35.397959183673464,4.915158092556973
Osteopontin signaling,0.004170759522527345,24.491764705882357,2.3797848499648087
Oxidative stress,0.20580514960848267,4.50530647606671,0.6865437626223331
PAC1 receptor pathway,0.28645885402936977,3.039181286549708,0.542937749791846
PD-1 signaling,2.100922107113971e-07,28.918443002780357,6.6775900490113145
PDGF genes and receptors,7.206474915652178e-10,311.7664670658683,9.142277120724303
PDGFA signaling pathway,4.9721940006670984e-06,23.954398894518658,5.303451934781897
PDGFB signaling pathway,5.3888280456075876e-11,14.47309573724668,10.268505674269113
PELP1 modulation of estrogen receptor activity,0.0018079446910869567,40.82745098039215,2.742814859658857
PI3K cascade,3.881723345960835e-11,26.723251028806583,10.410975420417023
PI3K class IB pathway in neutrophils,0.05042062885670246,5.822408963585434,1.2973917420135466
PI3K events in ERBB2 signaling,0.005953452034829257,8.785291631445478,2.2252311410029555
PI3K pathway,0.0009988473051553955,9.894285714285713,3.000500897756955
PI3K subunit p85 role in regulation of actin organization and cell migration,0.00033741224760654924,26.391377852916314,3.4718391571606393
PI3K/AKT activation,0.03867376153179705,6.794771241830065,1.412583585024032
PI3K/PLC/TRK pathway,0.03683252809025564,6.989243697478991,1.433768471262731
PIK3C1/AKT pathway,0.256450033837241,3.474185463659148,0.5909972392953379
PIP biosynthesis at the plasma membrane,0.2440981413739806,3.6850965798334223,0.612435527400088
PIP2 hydrolysis,0.19261703641072386,4.866198830409357,0.7153053034422358
PKB-mediated events,0.21231866831281923,4.344193817878028,0.6730118184161881
PTEN-dependent cell cycle arrest and apoptosis,0.0005555357979095127,21.730943264879915,3.25528795052393
Packaging of telomere ends,0.23784591152624435,3.8004385964912286,0.6237043095240977
Pancreatic beta-cell development regulation,0.23784591152624435,3.8004385964912286,0.6237043095240977
Pancreatic cancer,0.0027556459638260703,7.377754086709311,2.5597765798824574
Pathogenic Escherichia coli infection,7.868677446179506e-06,14.44114921223355,5.104098256979408
Pathways in cancer,2.790976571346121e-16,11.021657419008413,15.554243809150138
Peptide G-protein coupled receptors,0.4704730094620184,1.2711425931629197,0.3274652865362724
Peroxisome,0.4784377346775297,1.555705503073924,0.320174574596681
Phagosome,0.0017683883590587808,5.016333791542007,2.7524223526290768
Phase II of biological oxidations: conjugation,0.021322050231730637,5.340622588114227,1.6711710378482212
Phosphatidylinositol metabolism,0.3429114679852518,2.4301754385964913,0.4648179905355914
Phosphatidylinositol signaling system,0.4784377346775297,1.555705503073924,0.320174574596681
Phospholipase C signaling pathway,0.0865145785419486,12.174269005847954,1.0629107035543401
Phospholipase C-mediated cascade,1.5090514623278156e-08,21.568240788790867,7.821295949472985
Phospholipid metabolism,0.8177806017927114,0.5883040935672514,0.08736319536434456
Phospholipids as signaling intermediaries,5.210124316334795e-07,24.248348231636225,6.2831519140797285
Physiological and pathological hypertrophy  of the heart,0.020469777272207623,9.78964705882353,1.688886882788273
Plasma membrane estrogen receptor signaling,0.04637620879892532,6.1141176470588245,1.333704757315201
"Platelet activation, signaling and aggregation",1.663790132584485e-09,9.523470464135022,8.778901455694713
Platelet adhesion to exposed collagen,0.005689103652387648,20.4078431372549,2.244956153549875
Platelet aggregation (plug formation),0.00025810336589571177,14.561624649859946,3.5882063318358184
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions,2.933159853117878e-06,55.076719576719576,5.532664267931402
Platelet homeostasis,0.14813529364500297,3.0133623819898325,0.8293414572844879
Platelet sensitization by LDL,0.0093621332088001,15.30294117647059,2.0286251838200644
Plexin D1 signaling,0.017682993747721306,10.641943734015346,1.7524442066278376
Polo-like kinase 3 (PLK3) pathway,0.04815313595372715,24.354385964912282,1.3173754243639377
Post-chaperonin tubulin folding pathway,0.0004024632104012894,24.630769230769232,3.395273812811517
Post-translational regulation of adherens junction stability and disassembly,2.8892521312784563e-06,17.47128047072009,5.539214557690219
Pre-NOTCH expression and processing,0.08187370408500749,4.363865546218487,1.0868555610543207
Presenilin action in Notch and Wnt signaling,0.06105411382445477,5.201752190237798,1.2142850679833417
Primary immunodeficiency,0.03502641096032087,7.1951557093425595,1.4556043611117297
Prion diseases,0.03502641096032087,7.1951557093425595,1.4556043611117297
Progesterone-initiated oocyte maturation,0.016355364487588318,11.12620320855615,1.7863397729584753
Progesterone-mediated oocyte maturation,0.0007474266896523841,7.574850299401197,3.126431398108272
Prolactin activation of MAPK signaling,2.0196534588679284e-07,14.892395982783357,6.694723142341733
Prolactin receptor signaling pathway,0.12333860106558601,8.114230019493178,0.9089009817483877
Prolactin regulation of apoptosis,0.0029964539254473334,5.440172287004938,2.5233923957842217
Prostate cancer,3.3980226440014047e-09,16.00925925925926,8.468773731372773
Proteasome degradation,0.4097111835270607,1.9275039450478044,0.3875221813292541
Protein folding,0.009864105614825097,7.231813435433344,2.0059422864031813
Protein metabolism,0.7064437757643695,0.8225389994620763,0.1509223969391863
Protein processing in the endoplasmic reticulum,0.15754291007074672,2.2366863905325443,0.8026011366755464
Proteins and DNA sequences in cardicac structures,7.630891745524965e-05,20.63888888888889,4.117424707453887
Purine catabolism,0.0865145785419486,12.174269005847954,1.0629107035543401
Purine metabolism,0.7439396321324099,0.736842105263158,0.12846230436739045
RAGE pathway,1.6177911316312723e-09,22.060405851816896,8.791077549618313
RANKL regulation of apoptosis and immune response,0.023718226799275897,5.117357001972387,1.6249177824273155
RANKL signaling pathway,5.751321867884555e-06,15.327514138185396,5.240232326797232
RNA polymerase I promoter opening,0.02816720085131926,8.156078431372547,1.5502563093943345
RNA polymerase I transcription,0.0108936633403347,6.958244948085297,1.9628260503676542
RNA polymerase I transcription initiation,0.19261703641072386,4.866198830409357,0.7153053034422358
"RNA polymerase I, RNA polymerase III, and mitochondrial transcription",0.04437607554469008,3.957816377171216,1.3528511077968315
RSK activation,0.0013632929654565098,48.995294117647056,2.8654108062275094
RXR/VDR pathway,0.1992380848391284,4.678812415654521,0.7006276415421238
Rac1 cell motility signaling pathway,1.3181224673552244e-07,15.826219512195122,6.88004423737046
Ras activation upon calcium influx through NMDA receptor,0.15173213217560824,6.404739919975377,0.8189224393262989
Ras family activation regulation,0.23154227124842713,3.9232220335785697,0.6353697109351685
Ras signaling pathway,0.020469777272207623,9.78964705882353,1.688886882788273
Ras-independent pathway in NK cell-mediated cytotoxicity,0.0010876279960588895,16.7880580957504,2.9635196219953444
Rb tumor suppressor/checkpoint signaling in response to DNA damage,0.13052435023717956,7.60672514619883,0.884308460071737
Recruitment of repair and signaling proteins to double-strand breaks,0.07135800684164549,15.219298245614034,1.146557289093872
Recycling pathway of cell adhesion molecule L1,0.023426625887066368,9.063616557734205,1.6302902578883287
Reelin signaling pathway,4.197946856056462e-06,24.913772455089823,5.376963063673465
Regular glucocorticoid receptor pathway,0.000602938387860175,7.964839551665897,3.2197270646085068
Regulation of NFAT transcription factors,0.05887018693338069,5.3150895140664955,1.2301045851491557
Regulation of transcription by NOTCH1 intracellular domain,0.3264587028502455,2.5856662933930568,0.48617174933104784
Renal cell carcinoma,0.0002925694698993818,9.418435855561604,3.533770995182712
Repression of pain sensation by the transcriptional regulator DREAM,0.12333860106558601,8.114230019493178,0.9089009817483877
Response to elevated platelet cytosolic calcium,5.8315537403520825e-06,11.433057851239669,5.23421571780359
Retinoic acid receptor-mediated signaling,0.026547316655460486,8.437728194726166,1.5759793698977917
Rho GTPase cycle,0.6404175688202949,0.9844054580896687,0.19353676242255716
RhoA activity regulation,0.3208839421019777,2.642003559623697,0.49365201562806854
RhoA signaling pathway,0.006330976300767159,8.580569698637678,2.1985293122035823
S1P/S1P1 pathway,2.8328216810795958e-05,27.526455026455025,4.5477807623523185
S1P/S1P3 pathway,0.00010084058151370582,19.04945054945055,3.9963646585582118
S1P/S1P4 pathway,0.11609381364345954,8.69423558897243,0.9351909221399033
SHC-related events,0.1376515394741431,7.158926728586171,0.8612189271592329
SHC1 events in EGFR signaling,0.1376515394741431,7.158926728586171,0.8612189271592329
SHC1 events in ERBB2 signaling,0.019054732263666243,10.198039215686274,1.719997149081751
SHP2 signaling,2.3266386226171858e-08,20.271219512195124,7.633271066816849
SIDS susceptibility pathways,0.10712045571172804,3.7008912655971478,0.9701275884169973
SMAD2/3 nuclear pathway,0.030791295585270717,4.603846153846154,1.511572037186562
SREBF and miR-33 in cholesterol and lipid homeostasis,0.13052435023717956,7.60672514619883,0.884308460071737
SREBP control of lipid biosynthesis,0.07135800684164549,15.219298245614034,1.146557289093872
STAT3 pathway,0.0005555357979095127,21.730943264879915,3.25528795052393
Salivary secretion,0.5237239548965125,1.3627045140942242,0.2808975612112865
Second messenger role in netrin-1 signaling,0.0865145785419486,12.174269005847954,1.0629107035543401
Selenium pathway,0.08923592585429853,4.141375872382851,1.0494602660370937
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion,0.11609381364345954,8.69423558897243,0.9351909221399033
Sema3A/PAK-dependent axon repulsion,0.12333860106558601,8.114230019493178,0.9089009817483877
Semaphorin interactions,0.1045094088207639,3.7580090497737557,0.9808446089309524
Senescence and autophagy,0.0013985278658351092,6.53419476835802,2.8543288758367127
Serotonin HTR1 group and FOS pathway,0.0024591874934627896,12.306508875739645,2.609208358503207
Serotonin receptor 2 and ELK-SRF/GATA4 signaling,0.13052435023717956,7.60672514619883,0.884308460071737
Serotonin receptor 4/6/7 and NR3C signaling,0.144720643239773,6.760883690708251,0.8394695158354792
Serotonin transporter activity,0.09400038027098692,11.066985645933014,1.0268703894933098
Seven transmembrane receptor signaling through beta-arrestin,0.003361151787804024,6.9607645875251505,2.4735118745828237
Shigellosis,0.00016648886069039898,10.721660128019822,3.7786148186293027
Signal attenuation,0.005689103652387648,20.4078431372549,2.244956153549875
Signal regulatory protein (SIRP) family interactions,0.00018391067799036778,33.59386767079074,3.7353930545701513
Signal transduction,1.7992982640774964e-08,3.8839935101264405,7.744896839041245
Signal transduction by L1,4.3949331607278786e-07,25.05783132530121,6.357047725401992
Signal transduction of S1P receptor,0.18594156317429864,5.069200779727096,0.7306235223330885
Signal transduction through IL-1R,0.0405494222218335,6.610810810810811,1.3920153295578106
Signaling by EGFR in cancer,0.0003231716772270124,7.065924073653103,3.4905667078077536
Signaling by ERBB2,0.00020519479557723375,7.724878897031425,3.6878336585736347
Signaling by ERBB4,0.00012414487957955938,8.518619934282585,3.9060711884429007
Signaling by FGFR in disease,4.8843302916838515e-11,14.598568640208198,10.311194975561394
Signaling by FGFR mutants,1.1416320976978603e-10,31.026197977118223,9.942473829261754
Signaling by FGFR1 fusion mutants,0.01150235345890359,13.601307189542483,1.9392132909816573
Signaling by FGFR1 mutants,4.874227661262837e-09,36.77474747474748,8.312094190021803
Signaling by GPCR,0.17951904124812795,1.4032706648596223,0.7458894798410417
Signaling by NGF,1.5339925706933034e-05,6.002795248078267,4.814176743721273
Signaling by NOTCH,0.017129746156230165,4.251231527093596,1.766249072747586
Signaling by NOTCH1,0.02290394379881699,5.189682473539461,1.6400897306471984
Signaling by NOTCH2,0.11609381364345954,8.69423558897243,0.9351909221399033
Signaling by PDGF,1.5946251012058373e-12,16.842759261409824,11.797341403901646
Signaling by Robo receptor,0.23784591152624435,3.8004385964912286,0.6237043095240977
Signaling by SCF-KIT,2.7367490331222835e-07,14.2610786671247,6.562765026677371
Signaling by VEGF,0.09400038027098692,11.066985645933014,1.0268703894933098
Signaling by activated point mutants of FGFR1,2.6290317166844713e-08,89.05474764756201,7.580204174525831
Signaling by constitutively active EGFR,0.15173213217560824,6.404739919975377,0.8189224393262989
Signaling by insulin receptor,1.0869966662111793e-10,15.864795918367346,9.963771787880871
Signaling by interleukins,2.4203343569240556e-08,12.795061728395062,7.616124634293671
Signaling by the B cell receptor (BCR),0.03654596422752939,3.326898326898327,1.4371605752173866
Signaling events mediated by HDAC class I,0.11505646770753764,3.539471440750213,0.9390889631687915
Signaling events mediated by HDAC class II,0.2746026070256716,3.1994459833795013,0.5612953439692971
Signaling events mediated by PRL,0.17921122039723542,5.2898550724637685,0.7466348026869893
Signaling events mediated by PTP1B,4.3724299598603283e-10,26.08142777467931,9.359277138576513
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),2.6018408185390206e-05,16.38039710053577,4.584719277238241
Signaling events mediated by VEGFR1 and VEGFR2,1.349733520467755e-11,23.64886128364389,10.869751966330222
Signaling events mediated by focal adhesion kinase,1.2769964519365807e-05,13.171211160431199,4.893810309397904
Signaling events mediated by hepatocyte growth factor receptor (c-Met),5.035204287183623e-05,10.137088896125041,4.297982904654203
Signaling events mediated by stem cell factor receptor (c-Kit),4.616636768741946e-06,15.981286849525763,5.335674293856186
Signaling events mediated by the hedgehog family,0.17921122039723542,5.2898550724637685,0.7466348026869893
Signaling events regulated by Ret tyrosine kinase,1.057981000727534e-09,31.70121951219512,8.975522131311495
Signaling of hepatocyte growth factor receptor,7.213480870607237e-07,22.776560788608982,6.141855115572284
Signaling pathway from G-protein families,0.026547316655460486,8.437728194726166,1.5759793698977917
Signaling to ERKs,0.03683252809025564,6.989243697478991,1.433768471262731
Signaling to p38 via RIT and RIN,0.12333860106558601,8.114230019493178,0.9089009817483877
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,0.1586864731320332,6.084210526315791,0.7994600921140469
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK),0.001863154923962465,13.675871137409597,2.7297510314029454
Small cell lung cancer,0.005257239973293419,6.098471487360376,2.279242198614351
Splicing regulation through Sam68,0.0865145785419486,12.174269005847954,1.0629107035543401
Sprouty regulation of FGF signaling,0.008366614320089122,16.32392156862745,2.077450250437934
Sprouty regulation of tyrosine kinase signals,0.1586864731320332,6.084210526315791,0.7994600921140469
Stabilization of mRNA by HuR,0.07135800684164549,15.219298245614034,1.146557289093872
Stathmin and breast cancer resistance to antimicrotubule agents,0.02816720085131926,8.156078431372547,1.5502563093943345
Statin pathway,0.21877907501970922,4.194192377495463,0.6599942181615012
Steroid hormone biosynthesis,0.3746278005871242,2.169172932330827,0.42639999739968454
Striated muscle contraction,0.2746026070256716,3.1994459833795013,0.5612953439692971
Sulfation biotransformation reaction,1.2157433632847433e-05,35.397959183673464,4.915158092556973
Sulfur metabolism,0.10878950577119445,9.363472784525417,0.9634129962322838
Support of platelet aggregation by Eph kinases and ephrins,4.374152205548195e-05,61.603550295857985,4.359106109071674
Syndecan 1 pathway,0.3208839421019777,2.642003559623697,0.49365201562806854
Syndecan 2 pathway,0.00016634707856358547,16.506349206349206,3.778984821935857
Syndecan 3 pathway,0.1376515394741431,7.158926728586171,0.8612189271592329
Syndecan 4 pathway,2.550437276004893e-07,27.846050870147256,6.59338535279146
Systemic lupus erythematosus,0.10781920654756101,2.680991664147195,0.9673038685126121
T cell activation co-stimulatory signal,0.0007414861847603253,19.44160697601993,3.1298969362583247
T cell receptor calcium pathway,0.21877907501970922,4.194192377495463,0.6599942181615012
T cell receptor regulation of apoptosis,0.00013971267350458523,3.2829582689001113,3.854764196724319
T cell receptor signaling in naive CD4+ T cells,1.3931008497276825e-06,14.443020367610531,5.856017442876209
T cell receptor signaling in naive CD8+ T cells,0.0011454234040818904,9.512820512820513,2.9410339473273024
T cell receptor signaling pathway,2.351256004910797e-06,8.723504893925911,5.628700082288436
T cell receptor/JNK pathway,0.11609381364345954,8.69423558897243,0.9351909221399033
T cell receptor/Ras pathway,0.11609381364345954,8.69423558897243,0.9351909221399033
T cell signal transduction,2.9236162414371453e-08,15.278282208588955,7.534079634164266
T helper cell surface molecules,0.10878950577119445,9.363472784525417,0.9634129962322838
TAK1-mediated activation of p38 MAPK,0.0093621332088001,15.30294117647059,2.0286251838200644
TAp63 pathway,0.3694494827410325,2.2087187666135035,0.43244493715196763
TGF-beta regulation of extracellular matrix,9.936942848247654e-07,4.325528486112428,6.0027472079923205
TGF-beta regulation of skeletal system development,0.03369845270687466,4.4368004562629215,1.4723900396714884
TGF-beta signaling pathway,4.00363670431402e-07,8.063283052351375,6.397545337903502
"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",0.0009036596602798787,5.754772937905468,3.0439951043618803
TNF-alpha signaling pathway,2.101544485765552e-05,9.258755980861244,4.677461412359464
TNF/stress-related signaling,0.001521512945632253,14.771360946745562,2.8177243481413488
TP53 network,0.15173213217560824,6.404739919975377,0.8189224393262989
TPO signaling pathway,0.0012221315563822562,16.057370722922563,2.912882041936627
TRAIL signaling pathway,0.023426625887066368,9.063616557734205,1.6302902578883287
TSH regulation of gene expression,0.19169730822525236,2.5406862745098033,0.7173839853542117
TSP1-induced apoptosis in microvascular endothelial cell,0.07135800684164549,15.219298245614034,1.146557289093872
TWEAK regulation of gene expression,0.02192733606655957,9.41266968325792,1.6590141271855783
TWEAK signaling pathway,0.29812242510316045,2.894179894179894,0.5256053546206515
Tamoxifen metabolism,0.15173213217560824,6.404739919975377,0.8189224393262989
Telomerase protein component gene hTERT transcriptional regulation,0.004170759522527345,24.491764705882357,2.3797848499648087
Telomerase regulation,0.10712045571172804,3.7008912655971478,0.9701275884169973
Telomere maintenance,0.38991043785633434,2.0585786500148675,0.4090351386444507
"Telomeres, telomerase, cellular aging, and immortality",0.15173213217560824,6.404739919975377,0.8189224393262989
Thrombin signaling through protease-activated receptors,0.07237320241347016,4.700452488687783,1.1404222100224453
Thromboxane A2 receptor signaling,0.011430862232289046,6.829059829059829,1.9419210094470634
Thymic stromal lymphopoietin (TSLP) pathway,0.17112935048704503,2.7414408460013218,0.7666754979901623
Thyroid cancer,0.001863154923962465,13.675871137409597,2.7297510314029454
Thyroid-stimulating hormone signaling pathway,1.825580224189229e-05,12.305155046415168,4.7385990774460245
Tie2 signaling,0.01040767169280418,14.402076124567476,1.9826464159326678
Tight junction,0.6689753059176696,0.9099503143824472,0.17458991317631395
Tob role in T-cell activation,0.15173213217560824,6.404739919975377,0.8189224393262989
Toll receptor cascades,0.00035694915756369594,5.732818379877203,3.447393638683311
Toll-like receptor signaling pathway regulation,0.00017968355095643792,6.4547237076648845,3.7454916783491576
Transcription,0.18771901288942305,2.0477670159664143,0.726491738168278
Transcription factor regulation of microRNAs related to cardiac hypertrophy,0.07135800684164549,15.219298245614034,1.146557289093872
Transcriptional activity regulation by PML,0.144720643239773,6.760883690708251,0.8394695158354792
Transmembrane transport of small molecules,0.14571795776055502,1.7268982252193787,0.8364869240313902
Transmission across chemical synapses,0.20649388283834702,1.9488858114062695,0.6850928093291329
Trefoil factor initiation of mucosal healing,0.003974038766123354,10.252465483234714,2.4007679007311507
TrkA receptor signaling pathway,0.12333860106558601,8.114230019493178,0.9089009817483877
Tryptophan metabolism,0.3848579363064903,2.094172212139544,0.41469955325526836
Tumor necrosis factor (TNF) pathway,0.026547316655460486,8.437728194726166,1.5759793698977917
Tumor suppressor Arf inhibits ribosomal biogenesis,0.017682993747721306,10.641943734015346,1.7524442066278376
Type 2 diabetes mellitus,0.008430663795803622,7.68491124260355,2.074138229467165
Type I interferon (interferon-alpha/beta) pathway,0.008893807611462195,7.52771404419756,2.050912269330984
Type II interferon signaling (interferon-gamma),0.06550360376187245,4.988955582232893,1.1837348061022366
Ubiquitin-mediated proteolysis,0.6770943835484862,0.8897488820089439,0.16935078863060207
"Unblocking of NMDA receptor, glutamate binding and activation",0.1376515394741431,7.158926728586171,0.8612189271592329
Unfolded protein response,0.48272570894431727,1.5359390036272114,0.3162995709651728
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,2.6018408185390206e-05,16.38039710053577,4.584719277238241
VEGF signaling pathway,0.0036953605098381842,6.769406392694064,2.4323431865530556
"VEGF, hypoxia, and angiogenesis",0.04838286270842264,5.964705882352941,1.3153084389569816
VEGFR1 pathway,7.630891745524965e-05,20.63888888888889,4.117424707453887
Validated nuclear estrogen receptor alpha network,0.09934151922948163,3.8776844070961713,1.0028692026261237
Validated nuclear estrogen receptor beta network,0.12333860106558601,8.114230019493178,0.9089009817483877
Vascular smooth muscle contraction,0.002785029212206354,5.537852865697177,2.5551702451460914
Viral myocarditis,0.4474160998769182,1.7096614776377563,0.3492883922512324
Vitamin A and carotenoid metabolism,0.28055501156703794,3.1172589593642224,0.5519819690689869
Vitamin B12 metabolism,0.3536573685578604,2.3364822312190734,0.45141728883084736
Wnt interactions in lipid metabolism and immune response,0.05458695569994916,5.557219251336899,1.2629111255068226
Wnt signaling pathway,0.12349886588635232,2.1512113617376776,0.9083370305950893
Wnt signaling pathway and pluripotency,0.008951074776563107,5.196240601503759,2.048124814795098
Wnt/calcium/cyclic GMP pathway,0.12586120398012443,3.344883158742949,0.9001081181357807
Y branching of actin filaments,0.1655841291986373,5.7942077415761615,0.7809812915352176
YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.020469777272207623,9.78964705882353,1.688886882788273
cAMP cell motility pathway inferred from amoeba model,0.42887290202517714,1.8120799511215853,0.3676713934268627
"cAMP receptor, G-protein-independent pathways inferred from amoeba model",0.07896728809662318,13.527615334632877,1.1025527763201677
eIF4E and p70 S6 kinase regulation,0.02192733606655957,9.41266968325792,1.6590141271855783
fMLP induced chemokine gene expression in HMC-1 cells,0.00020861055242731773,15.473214285714286,3.6806637268536764
mRNA stability regulation by proteins that bind AU-rich elements,0.511775922774836,1.4104447164422684,0.2909201499689532
mTOR signaling pathway,0.002488441848072259,5.691094874471241,2.60407250374713
p38 MK2 pathway,0.1655841291986373,5.7942077415761615,0.7809812915352176
p38 alpha/beta MAPK downstream pathway,0.0405494222218335,6.610810810810811,1.3920153295578106
p38 gamma/delta MAPK pathway,0.004170759522527345,24.491764705882357,2.3797848499648087
p38-alpha and p38-beta regulation,4.9721940006670984e-06,23.954398894518658,5.303451934781897
p53 activity regulation,0.07441800411041907,3.1695572332177107,1.1283219819287713
p53 signaling pathway,0.10781920654756101,2.680991664147195,0.9673038685126121
p75 neurotrophin receptor-mediated signaling,0.0005806580600468297,6.29006783436266,3.2360795411924568
